Comparison sedation technique between Anesthesiologists and non-anesthesia providers in advanced gastrointestinal endoscopic procedures
Not Applicable
- Conditions
- cholelithiasis, cholecystitis, pancreatic cancer, gallbladder cancer, cholangiocarcinoma
- Registration Number
- JPRN-UMIN000033014
- Lead Sponsor
- Osaka City General Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 500
Inclusion Criteria
Not provided
Exclusion Criteria
None
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the molecular mechanisms of sedation techniques in advanced gastrointestinal endoscopy?
How does anesthesiologist-led sedation compare to non-anesthesia providers in managing adverse events during endoscopic procedures?
What biomarkers are associated with optimal sedation outcomes in patients with cholangiocarcinoma undergoing endoscopy?
Are there specific drug classes used in non-anesthesia provider sedation for pancreatic cancer endoscopic interventions?
What are the comparative effectiveness and safety profiles of sedation protocols in gallbladder cancer patients between anesthesiologists and non-anesthesia providers?